Centessa Pharmaceuticals plc Share Price
Equities
CNTA
US1523091007
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.48 USD | +3.49% | +0.21% | +19.10% |
24/04 | Exchange-Traded Funds Higher, Equity Futures Mixed Pre-Bell Wednesday Amid Earnings Deluge | MT |
24/04 | Centessa Pharmaceuticals Prices Equity Offering at $9.25 Per ADS | MT |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 1.05B 87.89B |
---|---|---|---|---|---|
Net income 2024 * | -195M -16.27B | Net income 2025 * | -209M -17.44B | EV / Sales 2024 * | - |
Net cash position 2024 * | 92.93M 7.75B | Net cash position 2025 * | 93.52M 7.8B | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-5.21
x | P/E ratio 2025 * |
-5.47
x | Employees | 76 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 88.4% |
Latest transcript on Centessa Pharmaceuticals plc
1 day | +3.49% | ||
1 week | +0.21% | ||
Current month | +3.49% | ||
1 month | -14.44% | ||
3 months | +18.35% | ||
6 months | +38.39% | ||
Current year | +19.10% |
Managers | Title | Age | Since |
---|---|---|---|
Saurabh Saha
CEO | Chief Executive Officer | 47 | 01/21/01 |
Director of Finance/CFO | 53 | 01/21/01 | |
Ellie Im
CTO | Chief Tech/Sci/R&D Officer | - | 03/23/03 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 61 | 23/21/23 | |
Chairman | 54 | 01/20/01 | |
Brett Zbar
BRD | Director/Board Member | 51 | 01/21/01 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.02% | 0 M€ | 0.00% | - | |
0.01% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
01/24/01 | 9.48 | +3.49% | 233,751 |
30/24/30 | 9.16 | -1.40% | 141,262 |
29/24/29 | 9.29 | +4.15% | 152,754 |
26/24/26 | 8.92 | -0.11% | 254,924 |
25/24/25 | 8.93 | -5.60% | 286,596 |
Delayed Quote Nasdaq, May 02, 2024 at 01:30 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.10% | 1.02B | |
+0.67% | 42.19B | |
+44.30% | 40.15B | |
-6.20% | 28.31B | |
+6.55% | 24.63B | |
-21.66% | 18.2B | |
+29.96% | 12.01B | |
-1.57% | 11.76B | |
+16.03% | 10.4B | |
-4.80% | 9.94B |
- Stock Market
- Equities
- CNTA Stock